Potentiation of Azole Antifungals by 2-AdamantanamineLAFLEUR, Michael D; LINGMEI SUN; DAHL, Thomas et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 8, pp 3585-3592, issn 0066-4804, 8 p.Article

Azole Resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the Role of ERG11GAST, Charles E; BASSO, Luiz R; BRUZUAL, Igor et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 11, pp 5478-5485, issn 0066-4804, 8 p.Article

Studies on the Antileishmanial Mechanism of Action of the Arylimidamide DB766: Azole Interactions and Role of CYP5122A1PANDHARKAR, Trupti; XIAOHUA ZHU; MATHUR, Radhika et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4682-4689, issn 0066-4804, 8 p.Article

Rigid, microporous 3D molecular frameworks derived from 3-amino-1,2,4-triazoleSCHLUETER, J. A; FUNK, R. J; GEISER, U et al.Journal of low temperature physics. 2006, Vol 142, Num 3-4, pp 429-432, issn 0022-2291, 4 p.Conference Paper

Performance and practical considerations for a new timber preservativeCONNELL, M.Journal of the Institute of Wood Science. 1994, Vol 13, Num 3, pp 433-437, issn 0020-3203Conference Paper

Novel 1,2,4-Thiadiazole Derivatives: Crystal Structure, Conformational Analysis, Hydrogen Bond Networks, Calculations, and Thermodynamic Characteristics of Crystal LatticesSUROV, Artem O; BUI, Cong Trinh; PROSHIN, Alexey N et al.The Journal of physical chemistry. B. 2013, Vol 117, Num 36, pp 10414-10429, issn 1520-6106, 16 p.Article

Antifungal prophylaxis with azole derivativesCASTAGNOLA, E; MACHETTI, M; BUCCI, B et al.Clinical microbiology and infection. Supplement. 2004, Vol 10, Num 1, pp 86-95, issn 1470-9465, 10 p.Article

History of the development of azole derivativesMAERTENS, J. A.Clinical microbiology and infection. Supplement. 2004, Vol 10, Num 1, pp 1-10, issn 1470-9465, 10 p.Article

Heteroresistance of Cryptococcus gattii to FluconazoleVARMA, A; KWON-CHUNG, K. J.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 6, pp 2303-2311, issn 0066-4804, 9 p.Article

Voriconazole Use for Endemic Fungal Infections 7FREIFELD, Alison; PROIA, Laurie; ANDES, David et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 4, pp 1648-1651, issn 0066-4804, 4 p.Article

Structure-antimicrobial activity relationships in azole-containing chemotherapeuticsPRODANCHUK, N. G; SINCHENKO, V. G; PETRUNIK, I. O et al.Antibiotiki i himioterapiâ. 1991, Vol 36, Num 5, pp 12-14, issn 0235-2990, 3 p.Article

Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazoleGERBER, Bernhard; GUGGENBERGER, Roman; FASLER, David et al.Blood. 2012, Vol 120, Num 12, pp 2390-2394, issn 0006-4971, 5 p.Article

Human Tissue Distribution of VoriconazoleWEILER, Stefan; FIEGL, David; MACFARLAND, Róisín et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 2, pp 925-928, issn 0066-4804, 4 p.Article

Resistance of clinically important yeasts to antifungal agentsODDS, F. C.International journal of antimicrobial agents. 1996, Vol 6, Num 3, pp 145-147, issn 0924-8579Article

Multifunctional activities of benzazole derivatives in rubber vulcanizationTAPAN KUMAR KHANRA; BASUDAM ADHIKARI; SUKUMAR MAITI et al.Rubber chemistry and technology. 1993, Vol 66, Num 1, pp 30-37, issn 0035-9475Conference Paper

The biology and chemistry of antifungal agents: A reviewKATHIRAVAN, Muthu K; SALAKE, Amol B; CHOTHE, Aparna S et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 19, pp 5678-5698, issn 0968-0896, 21 p.Article

Synthesis and nonlinear optical properties of donor-acceptor substituted triaryl azole derivativesMOYLAN, C. R; MILLER, R. D; TWIEG, R. J et al.Chemistry of materials. 1993, Vol 5, Num 10, pp 1499-1508, issn 0897-4756Article

Modulation of leukotriene metabolism from human polymorphonuclear granulocytes by bifonazoleBREMM, K. D; PLEMPEL, M.Mycoses. 1991, Vol 34, Num 1-2, pp 41-45, issn 0933-7407Article

Fluconazole inhibits human adrenocortical steroidogenesis in vitroDER PAS, R. Van; HOFLAND, L. J; HOFLAND, J et al.Journal of endocrinology. 2012, Vol 215, Num 3, pp 403-412, issn 0022-0795, 10 p.Article

Transcription Factor CCG-8 as a New Regulator in the Adaptation to Antifungal Azole StressXIANYUN SUN; KANGJI WANG; XINXU YU et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 3, pp 1434-1442, issn 0066-4804, 9 p.Article

In Vivo Emergence of Aspergillus terreus with Reduced Azole Susceptibility and a Cyp51a M217I AlterationARENDRUP, Maiken C; JENSEN, Rasmus H; GRIF, Katharina et al.The Journal of infectious diseases. 2012, Vol 206, Num 6, pp 981-985, issn 0022-1899, 5 p.Article

Voriconazole Pharmacokinetics in Liver Transplant RecipientsJOHNSON, H. J; HAN, K; ROMKES, M et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 2, pp 852-859, issn 0066-4804, 8 p.Article

Pharmacokinetics of Intracameral Voriconazole InjectionSHEN, Ying-Cheng; WANG, Mei-Yen; WANG, Chun-Yuan et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 2156-2157, issn 0066-4804, 2 p.Article

Synthesis and biological activity of some azoles and azinesEL-BAHAIE, S; ASSY, M. G; HASSANIEN, M. M et al.Pharmazie. 1990, Vol 45, Num 10, pp 791-792, issn 0031-7144, 2 p.Article

Facteurs d'inhibition relative: une nouvelle approche de l'évaluation in vitro des antibiotiques antifongiques = Relative inhibition factors: a new approach to the assessment of antifungal antibiotics in vitroODDS, F. C.Annales de dermatologie et de vénéréologie. 1989, Vol 116, pp 10-12, issn 0151-9638, suppl. 1Article